Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3

High FRMD3 expression is prognostic for worse survival in rectal cancer patients treated with CCRT

(2021) Tzu-Ju Chen et al.   International Journal of Clinical Oncology

Weighted Gene Co-expression Network Analysis Identified a Novel Thirteen-Gene Signature Associated With Progression, Prognosis, and Immune Microenvironment of Colon Adenocarcinoma Patients

(2021) Cangang Zhang et al.   Frontiers in Genetics

miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcinoma

(2020) Seref Bugra Tuncer et al.   Journal of Ovarian Research

Hsa-miR-375/RASD1 Signaling May Predict Local Control in Early Breast Cancer

(2020) Barbara Zellinger et al.   Genes

MicroRNA-3651 promotes the growth and invasion of hepatocellular carcinoma cells by targeting PTEN

(2019) Xinyang Zhao et al.   OncoTargets and Therapy

Combining laser microdissection and microRNA expression profiling to unmask microRNA signatures in complex tissues

(2019) Susanna Skalicky et al.   BIOTECHNIQUES

Clustered miRNAs and their role in biological functions and diseases

(2018) Shama P. Kabekkodu et al.   BIOLOGICAL REVIEWS

The altered expression levels of miR-186, miR-494 and miR-3651 in OSCC tissue vary from those of the whole blood of OSCC patients

(2018) Jutta Ries et al.   Cancer Biomarkers

Pan-cancer characterisation of microRNA across cancer hallmarks reveals microRNA-mediated downregulation of tumour suppressors

(2018) Andrew Dhawan et al.   Nature Communications

Single-trait and multi-trait genome-wide association analyses identify novel loci for blood pressure in African-ancestry populations

(2017) Jingjing Liang et al.   PLoS Genetics

Hsa-miR-375 is a predictor of local control in early stage breast cancer

(2016) Franz Zehentmayr et al.   Clinical Epigenetics

Clinical potential of miR-3651 as a novel prognostic biomarker for esophageal squamous cell cancer

(2015) Cong Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Circulating serum miRNAs as potential biomarkers for nephroblastoma

(2015) Nicole Ludwig et al.   PEDIATRIC BLOOD & CANCER

FRMD3 gene: its role in diabetic kidney disease. A narrative review

(2015) Marjoriê Piuco Buffon et al.   Diabetology & Metabolic Syndrome

miR-186, miR-3651 and miR-494: Potential biomarkers for oral squamous cell carcinoma extracted from whole blood

(2014) JUTTA RIES et al.   ONCOLOGY REPORTS

Evaluation of Candidate Nephropathy Susceptibility Genes in a Genome-Wide Association Study of African American Diabetic Kidney Disease

(2014) Nicholette D. Palmer et al.   PLoS One

A microRNA Signature Associated with Early Recurrence in Breast Cancer

(2014) Luis G. Pérez-Rivas et al.   PLoS One

Prediction of Response to Preoperative Chemoradiotherapy in Rectal Cancer by Using Reverse Transcriptase Polymerase Chain Reaction Analysis of Four Genes

(2013) Toshiaki Watanabe et al.   DISEASES OF THE COLON & RECTUM

MicroRNA-9 as Potential Biomarker for Breast Cancer Local Recurrence and Tumor Estrogen Receptor Status

(2012) Xin Zhou et al.   PLoS One

Global MicroRNA Expression Profiling of High-Risk ER+ Breast Cancers from Patients Receiving Adjuvant Tamoxifen Mono-Therapy: A DBCG Study

(2012) Maria B. Lyng et al.   PLoS One

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

(2011) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Assessing affymetrix GeneChip microarray quality

(2011) Matthew N McCall et al.   BMC BIOINFORMATICS

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials

(2011)   LANCET

A framework for oligonucleotide microarray preprocessing

(2010) Benilton S. Carvalho et al.   BIOINFORMATICS

Replication Study for the Association Between Four Loci Identified by a Genome-Wide Association Study on European American Subjects With Type 1 Diabetes and Susceptibility to Diabetic Nephropathy in Japanese Subjects With Type 2 Diabetes

(2010) Shiro Maeda et al.   DIABETES

Genome-Wide Association Scan for Diabetic Nephropathy Susceptibility Genes in Type 1 Diabetes

(2009) M. G. Pezzolesi et al.   DIABETES

The multi-FERM-domain-containing protein FrmA is required for turnover of paxillin-adhesion sites during cell migration of Dictyostelium

(2008) H. Patel et al.   JOURNAL OF CELL SCIENCE

The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial

(2008)   LANCET ONCOLOGY